Myrobalan's experimental therapy MRO-002 is a GPR17 antagonist that's made to promote myelin repair in people with MS and ...

The risk of developing MS and other demyelinating diseases is 3 times greater in individuals diagnosed with EBV-positive IM.

While diagnostic criteria for typical multiple sclerosis (MS) perform well in people ages 18 to 50, differential diagnoses in ...

Myelin, the protective sheath around nerve fibers, plays a crucial role in brain communication. It ensures fast and efficient ...

Myrobalan to receive over $850,000 in funding to advance the development of its GPR17 antagonist for progressive MS from the ...

There are several different ways that MS can cause nerve pain. Multiple sclerosis demyelination can affect the sensory regions of the brain and spinal cord, causing diminished sensation or ...

The study, “Presence of slowly expanding lesions in multiple sclerosis predicts progressive demyelination within lesions and normal-appearing tissue over time,” was published Multiple ...

The diagnosis and management of CIDP are complex and best addressed by an interprofessional health care team that includes neurologists, neuromuscular specialists, physical medicine and rehabilitation ...

The majority of the scholars focused on “multiple sclerosis” and “gut microbiota,” which are the primary keywords in the field of the intestinal microbiota and demyelinating diseases. Conclusion: This ...

Multiple sclerosis (MS) causes a specific type of damage, called demyelination, to the central nervous system, including the spinal cord. MS is a neurological disease. It causes the immune system ...

Natural treatments for multiple sclerosis can play a role in managing MS symptoms and possibly slowing the advance of the condition. Options include diet, exercise, and stress management strategies.